Phase II study of oxaliplatin based regimen in relapsed colon cancer patients treated with oxaliplatin based adjuvant

Trial Profile

Phase II study of oxaliplatin based regimen in relapsed colon cancer patients treated with oxaliplatin based adjuvant

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Oxaliplatin (Primary) ; Fluoropyrimidine derivatives
  • Indications Colon cancer; Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms INSPIRE
  • Most Recent Events

    • 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 01 Sep 2013 Planned end date 31 Aug 2017 added as reported by University Hospital Medical Information Network - Japan.
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top